The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions

Infectious Disease Clinics of North America

Volumn 21, Issue 1, 2007, Pages 241-257

  Sahasrabuddhe, Vikrant V ^a   Vermund, Sten H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CIRCUMCISION; CLINICAL TRIAL; DISEASE CONTROL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PROPHYLAXIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW;

CIRCUMCISION, MALE; HIV INFECTIONS; HUMANS; MALE;

EID: 34248191210     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.03.005     Document Type: Review

References (116)

1. UNAIDS/WHO AIDS epidemic update: December 2006. 2006. Available at: http://www.unaids.org. Accessed February 18, 2007.
2. The Power of Partnerships: Third Annual Report to Congress on PEPFAR. 2007. Available at: http://www.pepfar.gov/documents/organization/81019.pdf. Accessed April 12, 2007.
3. The Global Fund to fight AIDS, Tuberculosis and Malaria. Monthly Progress Update, 31 January 2007. Available at: http://www.theglobalfund.org/en/files/publications/basics/progress_update/progressupdate.pdf. Accessed April 12, 2007.
4. Global HIV Prevention Working Group. New approaches to HIV prevention: accelerating research and ensuring future access. Bill and Melinda Gates Foundation; Henry. J. Kaiser Family Foundation. 2006. Available at: http://www.kff.org/hivaids/hivghpwgpackage.cfm. Accessed February 18, 2007.
5. Stover J., Bertozzi S., Gutierrez J.P., et al. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science 311 (2006) 1474-1476
6. Corbett E.L., Makamure B., Cheung Y.B., et al. HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 21 (2007) 483-489
7. Thielman N.M., Chu H.Y., Ostermann J., et al. Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania. Am J Public Health 96 (2006) 114-119
8. O'Reilly K.R., and Higgins D.L. AIDS community demonstration projects for HIV prevention among hard-to-reach groups. Public Health Rep 106 (1991) 714-720
9. Martin D.J., Arns P.G., Batterham P.J., et al. Workforce reentry for people with HIV/AIDS: intervention effects and predictors of success. Work 27 (2006) 221-233
10. Walker D. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base?. Health Policy Plan 18 (2003) 4-17
11. Vassall A., and Compernolle P. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health Policy 79 (2006) 1-15
12. Janssen R.S., Holtgrave D.R., Valdiserri R.O., et al. Serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 91 (2001) 1019-1024
13. Liechty C.A. The evolving role of HIV counseling and testing in resource-limited settings: HIV prevention and linkage to expanding HIV care access. Curr HIV/AIDS Rep 1 (2004) 181-185
14. Gilks C.F., Crowley S., Ekpini R., et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368 (2006) 505-510
15. Bessinger R, Akwara P, Halperin D. Sexual behavior, HIV and fertility trends: a comparative analysis of six countries. Phase I of the ABC study. Measure Evaluation, USAID. 2003. Available at: http://www.cpc.unc.edu/measure/publications/pdf/sr-03-21b.pdf. Accessed February 17, 2007.
16. Mantell J.E., Harrison A., Hoffman S., et al. The Mpondombili project: preventing HIV/AIDS and unintended pregnancy among rural South African school-going adolescents. Reprod Health Matters 14 (2006) 113-122
17. Anyangwe S.C., Mtonga C., and Chirwa B. Health inequities, environmental insecurity and the attainment of the millennium development goals in sub-Saharan Africa: the case study of Zambia. Int J Environ Res Public Health 3 (2006) 217-227
18. Watkins S. Navigating the AIDS epidemic in rural Malawi. Popul Dev Rev 4 (2004) 673-705
19. Kirungi W.L., Musinguzi J., Madraa E., et al. Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect 82 Suppl 1 (2006) i36-i41
20. Sales J.M., Milhausen R.R., and Diclemente R.J. A decade in review: building on the experiences of past adolescent STI/HIV interventions to optimise future prevention efforts. Sex Transm Infect 82 (2006) 431-436
21. DiClemente R.J., Milhausen R., Sales J.M., et al. A programmatic and methodologic review and synthesis of clinic-based risk-reduction interventions for sexually transmitted infections: research and practice implications. Semin Pediatr Infect Dis 16 (2005) 199-218
22. Mast T.C., Kigozi G., Wabwire-Mangen F., et al. Immunisation coverage among children born to HIV-infected women in Rakai district, Uganda: effect of voluntary testing and counselling (VCT). AIDS Care 18 (2006) 755-763
23. Rasch V., Yambesi F., and Massawe S. Post-abortion care and voluntary HIV counselling and testing-an example of integrating HIV prevention into reproductive health services. Trop Med Int Health 11 (2006) 697-704
24. Aral S.O., Padian N.S., and Holmes K.K. Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview. J Infect Dis 191 Suppl 1 (2005) S1-S6
25. Manhart L.E., and Holmes K.K. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked?. J Infect Dis 191 Suppl 1 (2005) S7-S24
26. Salomon J.A., Hogan D.R., Stover J., et al. Integrating HIV prevention and treatment: from slogans to impact. PLoS Med 2 1 (2005) 50-56
27. Maticka-Tyndale E., and Brouillard-Coylea C. The effectiveness of community interventions targeting HIV and AIDS prevention at young people in developing countries. World Health Organ Tech Rep Ser 938 (2006) 243-285
28. Kirby D., Obasi A., and Laris B.A. The effectiveness of sex education and HIV education interventions in schools in developing countries. World Health Organ Tech Rep Ser 938 (2006) 103-150
29. Stoneburner R., and Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science 302 (2004) 714-718
30. Cleland J., and Ali M.M. Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data. Lancet 368 (2006) 1788-1793
31. Sangani P., Rutherford G., and Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection. Cochrane Database Syst Rev 2 (2004) CD001220
32. Ainsworth M., Beyrer C., and Soucat A. AIDS and public policy: the lessons and challenges of "success" in Thailand. Health Policy 64 (2003) 13-37
33. Phoolcharoen W. HIV/AIDS prevention in Thailand: success and challenges. Science 280 (1998) 1873-1874
34. Cohen J. Asia-the next frontier for HIV/AIDS. Two hard-hit countries offer rare success stories: Thailand and Cambodia. Science 301 (2003) 1658-1662
35. USAID, Senegal country profile. Available at: http://www.usaid.gov/locations/sub-saharan_africa/countries/Senegal. Accessed February 18, 2007.
36. Pisani E., Garnett G.P., Grassly N.C., et al. Back to basics in HIV prevention: focus on exposure. BMJ 326 (2003) 1384-1387
37. Wegbreit J., Bertozzi S., DeMaria L.M., et al. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS 20 (2006) 1217-1235
38. Rekart M.L. Sex-work harm reduction. Lancet 366 (2005) 2123-2134
39. Grosskurth H., Mosha F., Todd J., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346 (1995) 530-536
40. Wawer M.J., Sewankambo N.K., Serwadda D., et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353 (1999) 525-535
41. Kamali A., Quigley M., Nakiyingi J., et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomized trial. Lancet 361 (2003) 645-652
42. Korenromp E.L., White R.G., Orroth K.K., et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 191 Suppl 1 (2005) S168-S178
43. White R.G., Orroth K.K., Korenromp E.L., et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: a modeling study. J Acquir Immune Defic Syndr 37 (2004) 1500-1513
44. Grosskurth H., Gray R., Hayes R., et al. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 355 (2000) 1981-1987
45. Mayaud P., Mosha F., Todd J., et al. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 11 (1997) 1873-1880
46. Bailey R.C., Moses S., Parker C.B., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007) 643-656
47. Gray R.H., Kigozi G., Serwadda D., et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 (2007) 657-666
48. Auvert B., Taljaard D., Lagarde E., et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2 11 (2005) e298 1112-22 [Erratum in: PLoS Med 2006;3(5):e298;0705]
49. Weiss H.A., Thomas S.L., Munabi S.K., et al. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 82 (2006) 101-109
50. Weiss H.A., Quigley M.A., and Hayes R.J. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 14 (2000) 2361-2370
51. Siegfried N., Muller M., Volmink J., et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 3 (2003) CD003362
52. Siegfried N., Muller M., Deeks J., et al. HIV and male circumcision-a systematic review with assessment of the quality of studies. Lancet Infect Dis 5 (2005) 165-173
53. Gray R.H., Kiwanuka N., Quinn T.C., et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14 (2000) 2371-2381
54. Kahn J.G., Marseille E., and Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 3 (2006) e517 2349-58
55. Williams B.G., Lloyd-Smith J.O., Gouws E., et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 3 (2006) e262 1032-40
56. Middelkoop K., Myer L., Smit J., et al. Design and evaluation of a drama-based intervention to promote voluntary counseling and HIV testing in a South African community. Sex Transm Dis 33 (2006) 524-526
57. Sweat M., Gregorich S., Sangiwa G., et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356 (2000) 113-121
58. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet 356 (2000) 103-112
59. Fylkesnes K., and Siziya S. A randomized trial on acceptability of voluntary HIV counselling and testing. Trop Med Int Health 9 (2004) 566-572
60. Stringer J.S., Sinkala M., Stout J.P., et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr 32 (2003) 506-513
61. Grinstead O.A., Gregorich S.E., Choi K.H., et al. Positive and negative life events after counselling and testing: the Voluntary HIV-1 Counselling and Testing Efficacy Study. AIDS 15 (2001) 1045-1052
62. Latkin C.A., and Knowlton A.R. Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care 17 Suppl 1 (2005) S102-S113
63. Wawer M.J., Gray R.H., Sewankambo N.K., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191 (2005) 1403-1409
64. Cohen M.S., and Pilcher C.D. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 191 (2005) 1391-1393
65. Pronyk P.M., Hargreaves J.R., Kim J.C., et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet 368 (2006) 1973-1983
66. Hogan D.R., Baltussen R., Hayashi C., et al. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 331 (2005) 1431-1437
67. Dayton J.M., and Merson M.H. Global dimensions of the AIDS epidemic: implications for prevention and care. Infect Dis Clin North Am 14 (2000) 791-808
68. Green E. Rethinking AIDS prevention: learning from successes in developing countries (2003), Praeger Publishers, Westport (CT) Monograph, 374 pages
69. Dworkin S.L., and Ehrhardt A.A. Going beyond "ABC" to include "GEM": critical reflections on progress in the HIV/AIDS epidemic. Am J Public Health 97 (2007) 13-18
70. Elsey H., Tolhurst R., and Theobald S. Mainstreaming HIV/AIDS in development sectors: have we learnt the lessons from gender mainstreaming?. AIDS Care 17 (2005) 988-998
71. Elliott R., Csete J., Wood E., et al. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy. Health Hum Rights 8 (2005) 104-138
72. Ayres J.R., Paiva V., Franca Jr. I., et al. Vulnerability, human rights, and comprehensive health care needs of young people living with HIV/AIDS. Am J Public Health 96 (2006) 1001-1006
73. Prevention and control of sexually transmitted infections: draft global strategy. World Health Organization. May, 2006. Available at: http://www.who.int/gb/ebwha/pdf_files/WHA59/A59_11-en.pdf. Accessed on February 18, 2007.
74. Holmes K.K., DeLay P.R., and Cohen M.S. STD control: A public health priority. In: Dallabetta G.A., Laga M., and Lamptey P.L. (Eds). Control of sexually transmitted diseases: a handbook for the design and management of programs (1996), AIDSCAP/Family Health International, Airlington (VA) V-XII
75. May R.M., and Anderson R.M. The transmission dynamics of human immunodeficiency virus (HIV). Philos Trans R Soc Lond B Biol Sci 321 (1988) 565-607
76. Hogan D.R., and Salomon J.A. Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings. Bull World Health Organ 83 (2005) 135-143
77. Shelton J., Halperin D., Nantulya V., et al. Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ 328 (2004) 891-893
78. Halperin D., Steiner M., Cassell M., et al. The time has come for common ground on preventing sexual transmission of HIV. Lancet 364 (2004) 1913-1915
79. Laga M., Alary M., Nzila N., et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 344 8917 (1994) 246-248
80. Laga M., Manoka A., Kivuvu M., et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7 1 (1993) 95-102
81. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2 1 (2004) 33-42
82. Cohen M.S., Hoffman I.F., Royce R.A., et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349 9069 (1997) 1868-1873
83. Cohen M.S. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 12 (2004) 104-107
84. Wasserheit J.N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19 (1992) 61-77
85. Kalichman S.C., Rompa D., and Cage M. Sexually transmitted infections among HIV seropositive men and women. Sex Transm Infect 76 (2000) 350-354
86. Gilleece Y., and Sullivan A. Management of sexually transmitted infections in HIV positive individuals. Curr Opin Infect Dis 18 (2005) 43-47
87. Dallabetta G., Serwadda D., and Mugrditchian D. Controlling other sexually transmitted diseases. In: Gibney L., DiClemente R., and Vermund S. (Eds). Preventing HIV in developing countries: biomedical and behavioral approaches (1999), Kluwer Academic/Plenum Publishers, New York 109-136
88. World Health Organization. Training modules for the syndromic management of sexually transmitted infections. 2nd edition. Geneva, Switzerland: WHO Press. Available at: http://www.who.int/reproductive-health/stis/training.htm. Accessed February 18, 2007.
89. Hylton-Kong T., Brathwaite A.R., Del Rosario G.R., et al. Marginal validity of syndromic management for reproductive tract infections among pregnant women in Jamaica. Int J STD AIDS 15 (2004) 371-375
90. Cheluget B., Joesoef M.R., Marum L.H., et al. Changing patterns in sexually transmitted disease syndromes in Kenya after the introduction of a syndromic management program. Sex Transm Dis 31 9 (2004) 522-525
91. Behets F.M., Williams Y., Brathwaite A., et al. Management of vaginal discharge in women treated at a Jamaican sexually transmitted disease clinic: use of diagnostic algorithms versus laboratory testing. Clin Infect Dis 21 (1995) 1450-1455
92. Wolday D., Gebremariam Z., Mohammed Z., et al. The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1. AIDS 18 (2004) 781-785
93. Jenniskens F., Obwaka E., Kirisuah S., et al. Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Gynaecol Obstet 48 Suppl (1995) S121-S128
94. Sahin-Hodoglugil N.N., Woods R., Pettifor A., et al. A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa. Sex Transm Dis 30 (2003) 455-469
95. Geisler W.M., Yu S., Venglarik M., et al. Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections. Sex Transm Infect 80 5 (2004) 401-405
96. Adams E.J., Garcia P.J., Garnett G.P., et al. The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis 30 (2003) 379-387
97. Sanchez J., Gotuzzo E., Escamilla J., et al. Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination program. Sex Transm Dis 25 (1998) 82-89
98. Crabbe F., Tchupo J.P., Manchester T., et al. Prepackaged therapy for urethritis: the "MSTOP" experience in Cameroon. Sex Transm Infect 74 (1998) 249-252
99. Gangopadhyay D.N., Chanda M., Sarkar K., et al. Evaluation of sexually transmitted diseases/human immunodeficiency virus intervention programs for sex workers in Calcutta, India. Sex Transm Dis 32 (2005) 680-684
100. Hanenberg R.S., Rojanapithayakorn W., Kunasol P., et al. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 344 (1994) 243-245
101. Tuladhar S.M., Mills S., Acharya S., et al. The role of pharmacists in HIV/STD prevention: evaluation of an STD syndromic management intervention in Nepal. AIDS 12 Suppl 2 (1998) S81-S87
102. Behets F.M., Genece E., Narcisse M., et al. Approaches to control sexually transmitted diseases in Haiti, 1992-95. Bull World Health Organ 76 (1998) 189-194
103. Moherdaui F., Vuylsteke B., Siqueira L.F., et al. Validation of national algorithms for the diagnosis of sexually transmitted diseases in Brazil: results from a multicentre study. Sex Transm Infect 74 Suppl 1 (1998) S38-S43
104. Green M., Hoffman I.F., Brathwaite A., et al. Improving sexually transmitted disease management in the private sector: the Jamaica experience. AIDS 12 Suppl 2 (1998) S67-S72
105. Patterson B.K., Landay A., Siegel J.N., et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161 (2002) 867-873
106. Szabo R., and Short R.V. How does male circumcision protect against HIV infection?. BMJ 320 7249 (2000) 1592-1594
107. Weiss H.A. Male circumcision as a preventive measure against HIV and other sexually transmitted diseases. Curr Opin Infect Dis 20 (2007) 66-72
108. Mayaud P., and Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect 80 (2004) 174-182
109. USAID. Issue brief: male circumcision. 2007. Available at: http://www.usaid.gov/our_work/global_health/aids/TechAreas/research/issue_mc.pdf. Accessed February 18, 2007.
110. Halperin D.T., and Bailey R.C. Male circumcision and HIV infection: 10 years and counting. Lancet 354 (1999) 1813-1815
111. Wise J. Demand for male circumcision rises in a bid to prevent HIV. Bull World Health Organ 84 (2006) 509-511
112. WHO News Release: WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention. 28 March 2007. Available at: http://www.who.int/mediacentre/news/releases/2007/pr10/en/index.html. Accessed April 12, 2007.
113. Holmes K.K., Levine R., and Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 82 (2004) 454-461
114. Sawires S.R., Dworkin S.L., Fiamma A., et al. Male circumcision and HIV/AIDS: challenges and opportunities. Lancet 369 (2007) 708-713
115. Newell M.L., and Barnighausen T. Male circumcision to cut HIV risk in the general population. Lancet 369 (2007) 617-619
116. Gray R.H., Li X., Kigozi G., et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 21 (2007) 845-850